Protalix BioTherapeutics (NYSEMKT: PLX) · Protalix BioTherapeutics Return vs. S&P · Protalix BioTherapeutics Company Info · News & Analysis · Financial Health. a Barron's These Stocks Are Moving the Most Today: Palantir, Dell, Nvidia, Apple, Boeing, Oracle, and More · a Barron's Nvidia Stock Rises. But Citi. See the latest Protalix BioTherapeutics Inc stock price (PLX:XASE), related news, valuation, dividends and more to help you make your investing decisions. Complete Protalix BioTherapeutics Inc. stock information by Barron's. View real-time PLX stock price and news, along with industry-best analysis. About Protalix Biotherapeutics (PLX) ; Open. $ ; Price / earnings ratio. x ; Yesterday's range. $ - $ ; Debt / equity. x ; 52 week range. $ -.
Earnings Date. 01/01/ EPS EST. EPS PRIOR. EPS. Rev guidance. $10,,, PLX Stock Price. Upcoming PLX Catalysts. Drug. Stage. The average one-year price target for Protalix BioTherapeutics, Inc. is $ The forecasts range from a low of $ to a high of $ A stock's. Get Protalix Biotherapeutics Inc (PLX:NYSE American) real-time stock quotes, news, price and financial information from CNBC. Protalix BioTherapeutics, Inc. (onlineone.ru): Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Today's Editorial · Crypto. News for Protalix Biotherapeutics Stock (PLX) · Protalix BioTherapeutics, Inc. · Protalix BioTherapeutics Reports Second Quarter Financial and Business. View today's Protalix Biotherapeutics Inc stock price and latest PLX news and analysis. Create real-time notifications to follow any changes in the live. Protalix Biotherapeutics lowest stock price was $ and its highest was $ in the past 12 months. What is Protalix Biotherapeutics's market cap? This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since it has more than doubled. Protalix BioTherapeutics (AMEX:PLX) Stock Quotes, Forecast and News Summary ; 52 Wk Range, - ; Market Cap, $M ; P/E Ratio, - ; Dividend Yield, -. HACKENSACK, N.J. (AP) — Protalix BioTherapeutics Inc. PLX) on Wednesday reported a loss of $ million in its second quarter. The Hackensack, New Jersey-based. Protalix BioTherapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the American Stock Exchange with ticker PLX. The last closing price for.
Get Protalix Biotherapeutics Inc (PLX) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments. (PLX) stock quote, history, news and other vital information to help you with your stock trading and investing Current. High. View More. Company. Protalix BioTherapeutics Inc. · REAL TIME AM EDT 09/05/24 · USD · % · Volume, Given the current short-term trend, the stock is expected to fall % during the next 3 months and, with a 90% probability hold a price between $ and. The current price of PLX is USD — it has increased by % in the past 24 hours. Watch Protalix BioTherapeutics, Inc. (DE) stock price performance more. See the latest Protalix BioTherapeutics Inc stock price (PLX:XASE), related news, valuation, dividends and more to help you make your investing decisions. PLX Protalix BioTherapeutics Inc. 16, Market Cap, $M. Volume, , Wk High, $ Wk Low, $ About · Feed · News. Earnings are forecast to grow % per year · Trading at good value compared to peers and industry · Shareholders have been diluted in the past year · Does not. The current stock price of Protalix BioTherapeutics (PLX) is $1 as of September 6, What is the market cap of Protalix BioTherapeutics (PLX)?. The market.
Stocks; PLX. Protalix Today; Week; Month; Year; 5 Year; YTD. baraka onlineone.ru Stock News. Jim Cramer on American Express Company. (DE) Common Stock (PLX) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq. Protalix BioTherapeutics Inc. (PLX) reported a net income of $ million for Q3 , a significant improvement from a loss of $ million in the same. (NYSE:PLX) announced its quarterly earnings results on Wednesday, August, 14th. The company reported ($) earnings per share for the quarter, missing the. Protalix is dedicated to bringing to market recombinant therapeutic proteins with clinically improved profiles, produced with our ProCellEx® plant cell-based.
0. 0. 0. Sell. 0. 0. 0. Consensus. -. -. Buy. Stock Price Target PLX. High, $ Median, $ Low, $ Average, $ Current Price, $ Related. The average one-year price target for Protalix BioTherapeutics, Inc. is $ The forecasts range from a low of $ to a high of $ A stock's. What is Protalix BioTherapeutics Inc(PLX)'s stock price today? The current price of PLX is $ The 52 week high of PLX is $ and 52 week low is $
Life Insurance Policy Payout Questions | Goldman Sachs Apple Card Balance Transfer